Company location
Tel Aviv, Israel
RedHill Biopharma Ltd. has filed 1,019 SEC EDGAR filings since 01 Oct 2012

SEC filing history

Showing 51-75 of 1,000 matching filings.

Per page
25
Current page
3
6-K File 001-35773

6-K

Filing date
31 Dec 2025
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-87280

SCHEDULE 13G filing

Filing date
23 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
23 Dec 2025
Reporting date
23 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
15 Dec 2025
Reporting date
15 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
01 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
26 Nov 2025
Reporting date
26 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-281417

424B5

Filing date
26 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
04 Nov 2025
Reporting date
04 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
22 Oct 2025
Reporting date
22 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-288324

424B3

Filing date
21 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
21 Oct 2025
Reporting date
21 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-87280

SCHEDULE 13G filing

Filing date
20 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
20 Oct 2025
Reporting date
20 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 Oct 2025
Reporting date
06 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
29 Sep 2025
Reporting date
29 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-288324

EFFECT filing

Filing date
09 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276979

EFFECT filing

Filing date
09 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-276979

POS AM

Filing date
05 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-288324

POS AM

Filing date
05 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
20 Aug 2025
Reporting date
20 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
18 Aug 2025
Reporting date
18 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
14 Aug 2025
Reporting date
14 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
21 Jul 2025
Reporting date
21 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .